Clinical trial
Top Benefits of the Prenatal Diagnosis of the Fetal Esophageal or Intestinal Atresia
NCT05362604 is registered in ClinicalTrials.gov with Poitiers University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Top Benefits of the Prenatal Diagnosis of the Fetal Esophageal or Intestinal Atresia
- Lead sponsor
- Poitiers University Hospital
- Phase
- Observational
- Overall status
- Completed
- Start date
- April 1, 2021
- Completion date
- February 7, 2022
- Enrollment
- 51 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
antenatal management of the fetal gastrointestinal atresia